Cytodyn Inc (CYDY)

[HyGro]

As the issues the SEC and DOJ are ONLY Cytodyn activities -- it is very clear there is no other subject of the investigations. That's why the company is reporting the Investigations as it is material to the company.
The expanded investigation as described by the company:
"requesting documents and information concerning, among other matters, leronlimab, the Company’s public statements regarding the use of leronlimab as a potential treatment for COVID-19, HIV, and triple-negative breast cancer, related communications with the FDA, investors, and others, litigation involving former employees, the Company’s retention of investor relations consultants, and trading in the Company’s securities. Certain Company executives have received subpoenas concerning similar issues and may be interviewed by the DOJ or SEC in the future."

Nobody else could be under investigations for the subjects listed. All of the leading trade publications also have detailed descriptions of Cytodyn's SEC and DOJ investigation. They are clear of the nature of the investigation:
https://www.fiercebiotech.com/biotech/cytodyn-facing-sec-doj-investigations-over-public-claims-about-covid-19-drug-s-viability